ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1287

Development of the Academy for Workforce Advancement to Enrich Rheumatology Diversity

Eli Miloslavsky1, Greta Sirek2, Mia Chandler3, Renato Ferrandiz4, Grace Wright5, Maura Iversen6, Daniel Solomon2, Jeffrey Katz2, Ellen Gravallese7, Sciaska Ulysse8, Valerie Stone2, Gail Kerr9 and Candace Feldman2, 1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Boston Children’s Hospital, Boston, MA, 4North Alabama Medical Center, Florence, AL, 5AWIR, New York, NY, 6Johnson & Wales University, Boston, MA, 7Brigham and Women's Hospital, Harvard Medical School, Chestnut Hill, MA, 8University of California San Francisco, School of Medicine, San Francisco, CA, 9Washington DC VAMC/Georgetown and Howard Universities, Washington, DC

Meeting: ACR Convergence 2024

Keywords: Disparities, education, medical, Work Force

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Professional Education Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Workforce diversity enhances scientific inquiry and improves healthcare access and quality of care for minoritized populations. While other medicine subspecialties have increasing numbers of fellows identifying as underrepresented in medicine (URiM), the demographic composition of the adult and pediatric rheumatology and advance practice provider (APP) workforces has remained stagnant and is not reflective of the populations most affected by rheumatic conditions. We established a national Academy for Workforce Advancement to enrich Rheumatology Diversity (AWARD) to develop multimodal strategies to build racial and ethnic diversity in the pediatric and adult rheumatology and APP workforces.

Methods: We assembled 12 racially and ethnically diverse faculty and trainees (physicians, APPs, educators, students) from 8 institutions and national organizations with expertise in rheumatology, medical education, diversity, equity and inclusion, research, mentorship, pathway programs, and leadership. We established core domains (“pillars”), each led by a different AWARD member with relevant expertise. We considered interventions using consensus methods in large and smaller working group discussions. Pillar members conducted scoping surveys, and literature, and internet searches to assess existing resources, identify gaps, and develop goals, toolkits, and implementation processes.

Results: AWARD members agreed on four core pillars: 1) Mentoring Community, 2) Pathways Program Clearinghouse of Opportunities and Toolkits, 3) Social and Racial Justice and Advocacy Curriculum, and 4) URiM Leadership Program. Members of the mentoring pillar reviewed existing programs for URiM medical students, trainees, and APPs, developed an interview guide to obtain information about existing programs, and reviewed literature on mentorship pairing and training curricula. Pathways pillar members reviewed existing adult and pediatric rheumatology programs at AWARD-related institutions and Historically Black Colleges and Universities (HBCUs) and developed a rotation guide for URiM students, residents, and host programs. Curricular pillar members considered strategies to incorporate health equity concepts into medical and health professional education to enhance interest in rheumatology among URiM students and residents, and to implement an anti-racism and equity educational initiative checklist into rheumatology presentations. Leadership program members reviewed existing leadership training courses and identified potential leaders to serve as sponsors. All pillars identified gaps in URiM-focused initiatives to spark early interest in rheumatology and to facilitate leadership for URiM individuals in rheumatology and related APP fields (Table).

Conclusion: AWARD members have identified needs and opportunities within four pillars to build infrastructure and disseminate strategies to promote a more diverse rheumatology and APP workforce. Enhanced stakeholder engagement with national organizations and HBCUs is planned to pilot test materials and initiatives, with a goal for the national rollout of AWARD in the subsequent year.

Supporting image 1

Table 1. Needs Assessment, Current Landscape and Ongoing Activities for Each AWARD Pillar


Disclosures: E. Miloslavsky: None; G. Sirek: None; M. Chandler: None; R. Ferrandiz: None; G. Wright: AbbVie/Abbott, 2, 6, AstraZeneca, 1, 2, 6, AWIR, 4, Bristol-Myers Squibb(BMS), 2, 6, Eli Lilly, 2, 6, GlaxoSmithKlein(GSK), 2, Janssen, 2, 6, Novartis, 2, 6, Pfizer, 2, 6, UCB, 2, 6; M. Iversen: None; D. Solomon: Amgen, 5, Janssen, 5, Novartis, 5; J. Katz: None; E. Gravallese: Beam Therapeutics, 11, CRISPR Therapeutics, 11, Editas Medicine, 11, Intellia Therapeutics, 11, New England Journal of Medicine, 3, NIH, 5, Rheumatology Research Foundation, 5; S. Ulysse: None; V. Stone: None; G. Kerr: AstraZeneca, 1, Boehringer-Ingelheim, 6, Bristol-Myers Squibb(BMS), 1, CSL Behring, 6, Janssen, 6, Novartis, 1, Pfizer, 6, Sanofi, 6, UCB, 1; C. Feldman: Bain Capital, LP, 2, BMS Foundation, 5, Curio Bioscience, 12, My husband is a founder and will (but has not to date) receive equity., Harvard Pilgrim, 2, OM1, Inc., 2.

To cite this abstract in AMA style:

Miloslavsky E, Sirek G, Chandler M, Ferrandiz R, Wright G, Iversen M, Solomon D, Katz J, Gravallese E, Ulysse S, Stone V, Kerr G, Feldman C. Development of the Academy for Workforce Advancement to Enrich Rheumatology Diversity [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/development-of-the-academy-for-workforce-advancement-to-enrich-rheumatology-diversity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-of-the-academy-for-workforce-advancement-to-enrich-rheumatology-diversity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology